WK4- Modern Chemotherapy - ribs & nibs

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/33

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 10:06 PM on 5/15/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

34 Terms

1
New cards

What does PARP stand for?

Poly(ADP-ribose) polymerase – an enzyme that repairs single-strand DNA breaks.

2
New cards

What type of DNA damage does PARP repair?

Single-strand breaks (via base excision repair, BER).

3
New cards

What type of DNA damage do BRCA1 and BRCA2 repair?

Double-strand breaks (via homologous recombination).

4
New cards

What is synthetic lethality?

Two non-lethal events together cause cell death. BRCA mutation + PARP inhibition = cancer cell death.

5
New cards

Why are PARP inhibitors effective in BRCA-mutant cancers?

BRCA-mutant cells cannot repair double-strand breaks. PARP inhibitors cause single-strand breaks to become double-strand breaks. The cancer cell dies (synthetic lethality). Normal cells have working BRCA and survive.

6
New cards

What is the first PARP inhibitor licensed in Europe?

Olaparib – for BRCA-mutant ovarian, fallopian tube, and peritoneal cancer.

7
New cards

What happens when PARP is inhibited (Slide 7 diagram)?

Single-strand breaks collapse into double-strand breaks during replication. Without functional BRCA, the cell cannot repair them and dies.

8
New cards

What is the Philadelphia chromosome?

A translocation between chromosome 9 and 22 (t(9;22)) that creates the BCR-ABL fusion gene.

9
New cards

What cancer is associated with the Philadelphia chromosome?

Chronic Myelogenous Leukaemia (CML).

10
New cards

What is the BCR-ABL fusion protein?

A tyrosine kinase that is constitutively active (always ON). It constantly sends growth signals, causing uncontrolled proliferation of white blood cells.

11
New cards

What drug targets BCR-ABL?

Imatinib (Gleevec/Glivec) – a tyrosine kinase inhibitor.

12
New cards

Why did scientists originally think kinases were poor drug targets?

All kinases have a similar ATP-binding site, and there are over 500 kinases in the body. Selectivity was thought to be impossible.

13
New cards

How did Imatinib achieve selectivity?

It binds to the inactive conformation of BCR-ABL, not just the ATP-binding site common to all kinases.

14
New cards

What is the BRAF V600E mutation?

A point mutation (T to A at nucleotide 1799) changing valine (V) to glutamic acid (E) at position 600 of BRAF. Found in many melanomas.

15
New cards

How does BRAF V600E cause cancer?

The mutation makes BRAF constitutively active (always ON). It sends constant growth signals without needing upstream activation (Ras). This leads to uncontrolled proliferation of melanocytes (melanoma).

16
New cards

What drug targets BRAF V600E?

Vemurafenib – a selective BRAF inhibitor.

17
New cards

What interaction does vemurafenib make with glutamic acid (E) that it cannot make with valine (V)?

Glutamic acid has a negatively charged carboxylic acid side chain (COO⁻). It forms ionic and H-bond interactions with vemurafenib. Valine is hydrophobic – no ionic or H-bond interactions.

18
New cards

Why does vemurafenib not work on BRAF V600K?

V600K changes valine to lysine (K). Lysine has a positively charged bulky side chain (NH₃⁺) that either physically blocks vemurafenib (steric clash) or repels it (charge repulsion).

19
New cards

What drug works on both BRAF V600E and BRAF V600K?

Dabrafenib – it has a different chemical structure that fits around the lysine side chain.

20
New cards

What are two common resistance mechanisms to tyrosine kinase inhibitors?

1) Upregulation of other growth-related tyrosine kinases (bypass pathway). 2) Site mutations in the binding site of the target kinase (prevents drug binding).

21
New cards

What are the 4 types of drug-protein interactions?

1) Hydrophobic (water-hating groups stick together), 2) Pi-stacking (flat rings stack), 3) Hydrogen bonding (H sticks to O or N), 4) Ionic (positive and negative attract).

22
New cards

What functional groups on a drug do hydrophobic interactions?

Alkyl groups (CH₃, CH₂, CH), aromatic rings, CF₃ (trifluoromethyl), alkynes (C≡C), alkenes (C=C), halogens (F, Cl, Br, I).

23
New cards

What functional groups on a drug do pi-stacking interactions?

Aromatic rings (benzene, pyridine, etc.) – flat rings stack on each other.

24
New cards

What functional groups on a drug do hydrogen bonding?

NH (amines, amides, pyrrole), OH (alcohols), C=O (amides, ketones, aldehydes), N (pyridine, nitriles). NH and OH are H-bond donors. C=O and N lone pairs are H-bond acceptors.

25
New cards

What functional groups on a drug do ionic interactions?

Protonated amines (NH₃⁺ – positive charge) and deprotonated carboxylic acids (COO⁻ – negative charge). At pH 7.4, amines are often protonated, carboxylic acids are deprotonated.

26
New cards

What is the difference between valine (V) and glutamic acid (E) side chains?

Valine = hydrophobic alkyl (CH(CH₃)₂). Glutamic acid = negatively charged carboxylic acid (CH₂-CH₂-COO⁻).

27
New cards

What is the difference between valine (V) and lysine (K) side chains?

Valine = hydrophobic alkyl (CH(CH₃)₂). Lysine = positively charged amine (CH₂-CH₂-CH₂-CH₂-NH₃⁺).

28
New cards

What are the 8 functional groups in ponatinib?

Tertiary amines, pyridine nitrogens (2), pyrrole nitrogen, alkyne, amide, aromatic rings, alkyl substituents, trifluoromethyl (CF₃).

29
New cards

Complete the sentence: "Glutamic acid has a ___________ side chain that forms ionic and H-bond interactions with vemurafenib."

negatively charged (COO⁻)

30
New cards

Complete the sentence: "Valine has a ___________ side chain that cannot form ionic or H-bond interactions."

hydrophobic

31
New cards

Complete the sentence: "Lysine has a ___________ side chain that blocks vemurafenib binding due to steric clash or charge repulsion."

positively charged (NH₃⁺)

32
New cards

What is the difference between vemurafenib and dabrafenib?

Vemurafenib only works on BRAF V600E. Dabrafenib works on both BRAF V600E and V600K.

33
New cards

What is the T315I mutation?

A common resistance mutation in BCR-ABL (gatekeeper mutation). Threonine (T) to isoleucine (I) blocks imatinib binding.

34
New cards

What other cancer is imatinib used for besides CML?

Gastrointestinal Stromal Tumours (GIST) – driven by c-KIT mutation.